{"data":{"type":"company_profile","id":159501,"entity_id":"wefunder:company:159501","attributes":{"canonical_url":"https://wefunder.com/synergymed","generated_at":"2026-06-06T03:11:45Z","updated_at":"2026-06-05T05:01:10Z","entity_ids":{"company":"wefunder:company:159501","slug":"wefunder:company_slug:synergymed"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-06T03:11:45Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-05T05:01:10Z","as_of":"2026-06-06T03:11:45Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-05T05:01:10Z","as_of":"2026-06-06T03:11:45Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-10-13T19:08:25Z","as_of":"2026-06-06T03:11:45Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-10-13T19:08:25Z","as_of":"2026-06-06T03:11:45Z","confidence":"medium"}}},"company":{"id":159501,"entity_id":"wefunder:company:159501","slug":"synergymed","name":"SynergyMed Cancer Treatment Technology","tagline":"Destroying Tumors within Minutes","story":"Company Vision Statement:To redefine cancer care globally by establishing electromagnetic nanoparticle therapy as the first-line, non-invasive standard for solid tumor treatment delivering precise, rapid, and scalable tumor ablation across human and veterinary markets.Mission Statement:SynergyMed is building the future of oncology through a proprietary electromagnetic ablation platform that achieves rapid, non-invasive tumor destruction in days, not months. By leveraging our established electromagnetic technologies, we are accelerating regulatory pathways while unlocking a scalable, multi-indication treatment platform across human and veterinary oncology.Beginning in North America, we are implementing a disciplined geographic expansion strategy designed to maximize regulatory efficiency, clinical adoption, and global market penetration. Our platform positions SynergyMed to capture significant share in the multi-hundred-billion-dollar global oncology market while fundamentally transforming how solid tumors are treated worldwide.Mouse experiment showing complete disappearance of cancer tumors within 3 days using SynergyMed's noninvasive technology, with no visible damage to surrounding tissue.Disruptive Patented Technologies:Tailored RF and MW applicatorsFDA/CE approved nanoparticlesProprietary AlgorithmsAnimal Studies Results:Within 3–5 days the tumor volume diminishes to zeroRapid, definitive treatment: Single 10-minute treatmentNo cosmetic damageFewer follow upsImproved quality of lifeLess recovery timeCost Optimized:2x less than surgery3x less time per procedure. More time to help more patientsTreat several tumors simultaneouslyNo costly online image guidance (e.g. MRI)Our Non-Invasive technology combines electromagnetic energy, in the form of specialized microwave and radio frequency applicators, that interact with magnetic nanoparticles. The interaction is controlled by our proprietary algorithms, to ablate tumors precisely, effectively, and in a very short time without affecting the surrounding healthy tissue or leaving scars or cosmetic damage.(1) System combines different types of Electromagnetic Energy with Optical Thermal Sensing.(2) Tumors are injected with FDA-approved nanoparticles.(3) Special electromagnetic applicators are designed and optimized to interact with the nanoparticles.(4) The interaction of electromagnetic energy in the form of radio frequency and microwaves with nanoparticles leads to selective heating of the tumor.(5) Heating is controlled through optimized computer algorithms.(6) The synergistic effect of all these factors leads to maximal destruction of tumors at minimal energies and no damage to healthy tissue.Future projections are not guaranteedSeeking $1.2M. First Milestone of $500K has been reached(1) To perform clinical studies on dogs. Use data for pre-clinical human studies.(2) Veterinary product ready for sale.(3) Human device with regulatory preparations ready for performing human clinical studies.SynergyMed Devices Inc.The Non-Surgical 10 Min Solution to Destroy Cancer TumorsThe non-surgical solution for treatment of cancer tumorsWe’ve developed a disruptive, noninvasive cancer treatment that eliminates tumors in as little as three days — with zero damage to surrounding healthy tissue.In just one 10-minute outpatient session, our patented technology precisely targets and destroys cancer cells without surgery, cosmetic damage, or recovery time.It’s a faster, safer, and more cost-effective alternative to traditional cancer surgery — with the potential to transform care for millions and capture a multi-billion-dollar market.About CompanySynergyMed Devices Inc. is developing a noninvasive electromagnetic ablation system to treat cancerous tumors — offering a safer, surgery-free alternative for both human and veterinary patients.Risks of SurgeryHigh Impact on Quality of Life – Surgery often leads to pain, long recovery, and lasting lifestyle changes.Not Always an OptionSevere Functional Impact – Head \u0026amp; neck surgeries, including tongue cancer, can impair speaking, eating, and breathing.High Re-Excision Rates – Up to 40% of breast cancer surgeries require follow-up operations to remove remaining tumor tissue.Limited Surgical Eligibility – 75% of lung cancer patients are not candidates for surgery due to age, tumor location, or comorbidities.Cosmetic \u0026amp; Emotional Toll – Procedures can result in disfigurement, scarring, and emotional distress, especially in visible areas like the breast or face.Cost Prohibitive:Cancer surgery doesn’t end in the operating room.It often requires costly follow-ups, repeat procedures, and long recovery times — placing a heavy financial and emotional burden on patients and families.We believe there's a better way.No Viable Alternative Technology to Surgery:Conventional ablation devices require image guidance, damage healthy tissue, lack feedback mechanisms, and lack treatment dose evaluation.Today, the most common treatment for early-stage solid cancer tumor patients is surgery.But, surgery, while effective, may significantly impact quality of life, come with many risks and a long recovery time.What we have is:A Noninvasive Ablation DeviceDisruptive Patented TechnologiesTailored RF and MW applicatorsFDA/CE approved nanoparticlesProprietary AlgorithmsAnimal Studies Results:Within 3-5 days the tumor volume diminishes to zeroRapid, definitive treatment: Single 10-minute treatmentNo cosmetic damageFewer follow upsImproved quality of lifeLess recovery timeCost Optimized:2x less than surgery3x less time per procedure. More time to help more patientsTreat several tumors simultaneouslyNo costly online image guidance (e.g. MRI)Our goal is to put an end to painful cancer surgery.Our Non-INVASIVE technology combines electromagnetic energy in the form of microwaves and radio frequency with nanoparticles, controlled by our proprietary algorithms, to ablate tumors precisely, effectively, and in a very short time without affecting surrounding healthy tissue or leaving any cosmetic damage.Our innovation lies in performing truly noninvasive electromagnetic ablation, precisely targeting superficial tumors while sparing healthy tissue and avoiding any cosmetic damage.With this capability we can potentially treat many superficial tumors including breast, skin, tongue, thyroid, head \u0026amp; neck.No costly, live-imaging guided modalities (like MRI) are needed to monitor the ablation procedure.Our device is versatile and may be used not only in hospitals, but also in cancer clinics.How Our Solution Works(1) System combines different types of Electromagnetic Energy with Optical Fiber Thermal Sensing.(2) Tumors are injected with FDA approved nanoparticles.(3) Special electromagnetic applicators are designed and optimized to interact with the nanoparticles.(4) The interaction of electromagnetic energy in the form of radio frequency and microwaves with nanoparticles leads to selective heating of the tumor.(5) Heating is controlled through optimized computer algorithms.(6) The synergistic effect of all these factors leads to maximal destruction of tumors at minimal energies and no damage to healthy tissue.How does SynergyMed's technology differ from traditional cancer treatments?It is nonivasive, selective in treating tumors without damaging healthy tissue, no image guidance is required, provides dose evaluation, does not require expensive imaging tools during treatment, and uses a lower concentration of nanoparticles.The potential market for our product is significant.A combined use of the technology for veterinary applications and human superficial tissue can lead to a market of over $50 Billion.Potential Human Market Size for Our Application:Human Breast Cancer Therapy Market: $24B Worldwide.Cancer Surgery Market: $52.3BOur first go-to-market will be veterinary.Veterinary Market:Why veterinary market first?This market doesn't require FDA approval for medical devices, which makes for easier entry, and allows us to start generating revenue faster. The data collected will also help us accelerate our FDA application process to expand into the human market.Our Milestones:-Convert Prototype to Product. Ready for clinical studies. Completed-Build 1 Prototype. Completed-Mice studies successfully completed.-Dog studies successfully completed-Extended clinical studies on dogs in the US. (We are here!)-Certify ready product-Perform First in Human Studies on 5 patients.-Start sales in veterinary market-Continue First in Human on 10 patients.-Expand veterinary sales by working with strategics-Start human clinical trials on 60-80 patients. At 3 different sites.-Continue human clinical trials.-Submit for FDA approvalStart sales for human marketBusiness \u0026amp; Pricing ModelWe generate revenues from selling devices to veterinary and human clinics, and consumables sales for each patient treatedDirect sales to clinicsThrough specialized sales reps, SynergyMed sells its devices to large vet hospitals and cancer/oncology human clinics.These clinics treat approx. 80 patients per month, with Synergy Med aiming to treat up to 30%.SynergyMed handles consumables deliveries and device maintenance, charging an annual fee of $5,000 per clinic.Human device: $200,000Veterinary device: $100,000Consumables: $1,500 / treatmentAnnual maintenance fee: $5,000Devices sales to pay-per-use distributorsSynergyMed sells devices to distributors who rent them to clinics that are not willing to acquire the device.Though these clinics treat fewer patients (~40 per month), they perform fewer surgeries, so up to 40% of their patients could use Synergy Med.Those distributors oversee the maintenance of the device and the consumable deliveries.Human device: $200,000Veterinary device: $100,000Consumables: $1,200/ treatment (post-distributor commission)Our business model allows for the device to be sold in full or leased at a pay-per-use option, with continuous generation from consumables. revenueCombined Revenue ProjectionRevenues will increasingly be driven by consumables sales, enhancing the scalability of our model. Anticipated to reach over $100 million by 2030 (not guaranteed)Due DiligenceOur company has been vetted and qualified by various grantors and venture capitalists (VCs). Through rigorous due diligence with these institutions, we were awarded several prizes and grants, including:Merage (Orange County, California) Institute +45 Competition: Won the second prize out of 400 medical device startups.Russia (Moscow): Won the Gold Medal of the Archimedes conference of science and technology amongst 27 countries.World Economic Forum: Company chosen in the top 100 startups.New England Venture Summit (Boston): Chosen amongst the top 20 medical device companies to present at the summit.USAID: Won several grants to convert our prototype into a device.World Bank: Won numerous grants to train our employees, purchase equipment, and hire new team members.Seeking:$1.2M in crowdfunding (Initial $500K Target Reached)Milestone Phases:(1) Dog Clinical Studies and Pre-Clinical preparation for the FDA(2) Veterinary Device Ready of Sale(3) Human Device Ready for Clinical StudiesHow are we going to use the money?1) Build Veterinary Product (~37.5%)2) Clinical Studies on Dogs (~31.3%)3) Veterinary Product Marketing (~18.8%)4) Preparations for Human Clinical Studies (~12.5%)Our crowd-funding goals aim to:(1) publicly advertise the company and its product(2) give our friends and network access to investing in our startup(3) help us reach our milestones swiftly and smoothlyMANAGEMENT TEAM \u0026amp; ADVISORSWe are an experienced team of MTM management, technical, and medical leaders with backgrounds from leading corporate and academic institutions.Executive LeadershipDr. Anan Copty, PhD - Founder \u0026amp; CEO25+ years R\u0026amp;D experience in medical physics. Specialist in cancer treatment technologies. Deep technical expertise in electromagnetic ablation, product development, and technology innovation. Seasoned entrepreneur.Dr. Daniel Kacher, PhD - Clinical Studies \u0026amp; Product Development. Biomedical Engineering doctorate. 25+ years at Brigham and Women's Hospital. Expert in clinical trial design and execution. Dr Kacher is the author of numerous scientific and medical papers and brings high level of experience in thermal ablation, medical device development and medical imaging.Yahya Dajani - Business \u0026amp; Customer Development. Medical technology entrepreneur. 10+ years corporate leadership experience. Proven track record in medtech commercializationRobert Roy - Marketing \u0026amp; Sales35+ years senior management in US medical device companies. Deep industry relationships and market knowledgeMimi Copty, MHA - COO25+ years of project management \u0026amp; leadership experience in health organizations in the US and internationally. Sales experience.Medical Advisory BoardDr. Nader Hanna – Professor of Surgical Oncology, Thomas Jefferson University, PennsylvaniaDr. Salem Billan - Director of Head \u0026amp; Neck Oncology, Rambam Medical CenterJoin us in the fight to make Effective Treatment Accessible!Invest Today!","location":"Boston, MA","website":"https://SynergyMedDevices.com/","total_amount_raised":755375,"total_investors":549,"is_funded":true,"is_active":true,"quality_score":2,"related_urls":["https://wefunder.com/synergymed","https://SynergyMedDevices.com/"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/159501/xxl_avatar.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/159501/large_blob.png","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/159501/standard_avatar.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/159501/standard_avatar.jpg"},"links":{"company_url":"https://SynergyMedDevices.com/","linkedin_url":"https://linkedin.com/company/synergymed-ltd/posts/?feedView=all","twitter_url":"https://x.com/Synergymedtech","facebook_url":"https://facebook.com/people/SynergyMed/100048974187001/","instagram_url":"https://instagram.com/synergymeddevices/reel/DCeuQeZtAcX/","youtube_url":"https://youtube.com/@SynergyMedCancerTechnology","tiktok_url":"https://tiktok.com/@synergymedd?_t=ZT-8u2UcpBlHha\u0026_r=1"},"highlights":[],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"Tumor Removal with No Surgery, No Scars and No Pain"},{"index":2,"claim_id":"claim-fact-2","value":"Signed LOI's from Boston Scientific and Medtronic."},{"index":3,"claim_id":"claim-fact-3","value":"$100 million projected revenue within 5 years (not guaranteed)."},{"index":4,"claim_id":"claim-fact-4","value":"10 minute non-invasive treatment to cure cancer in dogs and mice."},{"index":5,"claim_id":"claim-fact-5","value":"Building collaborations with leading U.S. institutions including Ohio State and Harvard."}],"team":[{"id":5079330,"entity_id":"wefunder:company_role:5079330","user_entity_id":"wefunder:user:4405894","role":"founder","name":"Anan Copty","title":"CEO","bio":"25+ years of technical \u0026amp; leadership experiences, RMD: Radiation Monitoring Devices, Intel: Biochips, Harvard Medical School: MRI","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5079330/square_blob.jpg?1771068615","profile_url":"https://wefunder.com/anan.copty","linkedin_url":"https://linkedin.com/in/anan-copty-phd-7089a3b/","related_urls":["https://wefunder.com/anan.copty"]},{"id":5032210,"entity_id":"wefunder:company_role:5032210","user_entity_id":"wefunder:user:4383108","role":"founder","name":"Yahya Dajani","title":"VP of Business Development","bio":"Medical Technology Entrepreneur. Co-founded NCA Monitoring Technologies \u0026amp; D\u0026amp;O LLC ADNOC Oil Company Corporate Planning, Finance, Performance, and Business Development","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5032210/square_blob.jpg?1771068615","profile_url":"https://wefunder.com/yahya.dajani","linkedin_url":"https://linkedin.com/in/strive1/","related_urls":["https://wefunder.com/yahya.dajani"]},{"id":5128187,"entity_id":"wefunder:company_role:5128187","role":"employee","name":"Daniel Kacher, Ph.D.","title":"Director of Clinical Studies  and Product Development","bio":"Ph.D. in Biomedical Engineering 25 years at Brigham and Women’s Hospital","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5128187/square_blob.jpg?1771068615","related_urls":[]},{"id":5128272,"entity_id":"wefunder:company_role:5128272","role":"employee","name":"Robert Roy, MBA,  BSEE/BSME","title":"VP of Marketing, Sales","bio":"35+ years of senior-level management in medical device companies","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5128272/square_blob.jpg?1771068615","related_urls":[]},{"id":5128277,"entity_id":"wefunder:company_role:5128277","role":"founder","name":"Mimi Copty, MHA","title":"COO","bio":"25+ years of project management \u0026amp; leadership experiences in health organizations in the US and internationally","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5128277/square_blob.jpg?1771068615","related_urls":[]}],"featured_investors":[{"id":9913,"entity_id":"wefunder:company_investor_profile:9913","investor_profile_id":3979340,"investor_profile_entity_id":"wefunder:investor_profile:3979340","subject_entity_id":"wefunder:user:4488139","name":"Teresa Cornella","role_title":"","avatar_url":"https://uploads.wefunder.com/2021/user_default_icon_circle.png","profile_url":"https://wefunder.com/teresa.cornella.1","endorsement_quote":"Cancer treatment has long been associated with daunting procedures, lengthy recovery periods, and a profound impact on quality of life. Traditional surgery, while often effective, can be invasive and painful, leaving patients and their families searching for better alternatives. In this landscape, SynergyMed stands out as a beacon of hope, offering a revolutionary approach to cancer treatment. SynergyMed” precise, noninvasive methodology marks a significant leap forward in oncology. Their cutting edge technology focuses on treating tumors with exceptional accuracy, limiting collateral damage to surrounding healthy tissue. This precision is not just a technological advancement. It represents a fundamental shift in patient care. For patients, this means a treatment option that drastically reduces the physical and emotional burden typically associated with cancer surgery.I am excited to support SynergyMed and their groundbreaking work in revolutionizing cancer treatment. Their precise, non-invasive approach to treating tumors is a game-changer. By eliminating the pain and invasiveness of traditional surgery, SynergyMed aims to transform cancer care.","endorsement_name":"","investment_total":10000,"investment_info":"Invested $10,000 this round","is_lead_investor":true,"related_urls":["https://wefunder.com/teresa.cornella.1"]}],"investor_memos":[],"tab_counts":{"posts":0,"ask_questions":62,"featured_investors":1,"faq_entries":5},"active_fundraises":[{"id":118997,"entity_id":"wefunder:fundraise:118997","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":500,"max_purchase":9,"funding_target":1235000.0,"minimum_target":"50000.0","maximum_target":"1235000.0"},{"id":118996,"entity_id":"wefunder:fundraise:118996","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"safe","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":500,"max_purchase":9,"funding_target":50000.0,"minimum_target":"50000.0","maximum_target":"1235000.0","funding_started_at":"2024-11-01T22:50:12Z","funding_closed_at":"2026-04-16T03:59:59Z","auto_close_at":"2026-04-16T03:59:59Z"}],"latest_fundraise":{"id":118997,"entity_id":"wefunder:fundraise:118997","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null,"terms":{"eb":null,"nb":"$16M","txt":"valuation cap"}},"recent_posts":[],"q_and_a":[{"id":314834,"entity_id":"wefunder:comment:314834","question":"Do you know about LSN: https://www.lifesciencenation.com/workshops/","author_name":"Thomas Klauset Aurdal","votes":2,"created_at":"2025-09-12T18:25:57Z","canonical_url":"https://wefunder.com/synergymed#question-314834","answers":[{"id":314852,"entity_id":"wefunder:comment:314852","answer":"Yes we do. Thanks for sharing.","author_name":"Anan Copty","votes":1,"created_at":"2025-09-12T18:42:22Z"},{"id":329683,"entity_id":"wefunder:comment:329683","answer":"Dear Thomas, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:41:24Z"}]},{"id":314404,"entity_id":"wefunder:comment:314404","question":"Does this use soundwaves to break up the tumors. I know the tech been around for almost a century and it was hidden because it was \"too cheap\"","author_name":"Richard S Arena","votes":2,"created_at":"2025-09-05T00:55:37Z","canonical_url":"https://wefunder.com/synergymed#question-314404","answers":[{"id":314428,"entity_id":"wefunder:comment:314428","answer":"Hi Richard. Good question. So, technologies that use soundwaves (focused ultrasound) typically treat deep seated tumors like the liver tumors for example. At SynergyMed, we use electromagnetic energy like radio frequency waves that interact with FDA approved nanoparticles inserted into the tumor prior to the treatment. With this, we have the ability to treat superficial tumors selectively without damaging healthy tissue. We heat the tumors to higher temperatures where the cancer is destroyed. It has the advantage of sparing healthy tissue, it is cost-effective, one treatment session and the person can go home on the same day, and does not cause cosmetic damage. Let us know if you have further questions.","author_name":"Anan Copty","votes":1,"created_at":"2025-09-05T13:37:35Z"},{"id":322767,"entity_id":"wefunder:comment:322767","answer":"Dear Richard, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:21:17Z"},{"id":329684,"entity_id":"wefunder:comment:329684","answer":"Dear Richard, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:42:19Z"}]},{"id":314288,"entity_id":"wefunder:comment:314288","question":"Are you still looking for animals to test on? My dog has cancer (an oral tumor) he was just diagnosed with last week.","author_name":"Nikki Wise","votes":2,"created_at":"2025-09-03T16:51:15Z","canonical_url":"https://wefunder.com/synergymed#question-314288","answers":[{"id":314333,"entity_id":"wefunder:comment:314333","answer":"Hi Nikki. Thanks for the question. We are currently running a clinical study for dogs at Ohio State University. If that is feasible for you, you are welcome to have your dog join the study. The experts will first analyze and see if the case matches the needs of the study. Feel free to contact me for more questions through LinkedIn https://www.linkedin.com/in/anan-copty-phd-7089a3b/. Wishing your dog a safe recovery and all the best to your as well.","author_name":"Anan Copty","votes":1,"created_at":"2025-09-04T10:16:59Z"},{"id":322768,"entity_id":"wefunder:comment:322768","answer":"Dear Nikki, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:21:58Z"}]},{"id":311958,"entity_id":"wefunder:comment:311958","question":"Can you provide us an overview of interest in the product from veterinarians, What is the number of veterinarians that are large enough to purchase the equipment ? Of that group, what is the number of veterinarians who treat enough cancer victims where your equipment makes sense ? Approximately how many of these veterinarians have you approached ? What percentage have shown interest in the product by requesting a call back or signing a LOI ?","author_name":"Stanley Winderman","votes":2,"created_at":"2025-07-27T04:37:33Z","canonical_url":"https://wefunder.com/synergymed#question-311958","answers":[{"id":312078,"entity_id":"wefunder:comment:312078","answer":"Thank you, Stanley, for the thoughtful questions. We're not exactly following that pathway. Instead, we've engaged directly with large, high-end veterinary hospitals that specialize in oncology, and we've confirmed their interest through conversations with executives, business development professionals, and chief medical officers. Additionally, we've secured interest from major distributors of medical devices in the veterinary space. Before that, we conducted interviews with veterinary oncologists to better understand the unmet needs in the field. Currently, our focus is on continuing clinical studies in collaboration with one of the world’s leading institutions, The Ohio State University (einpresswire.com/art…reatment-technology). The results from this research will support our efforts to begin working directly with these hospitals and distributors to bring our device to market. We’ve taken a similar approach in the human healthcare market, as demonstrated by the Letters of Intent (LOIs) featured on our WeFunder page.","author_name":"Anan Copty","votes":1,"created_at":"2025-07-29T09:19:03Z"},{"id":329685,"entity_id":"wefunder:comment:329685","answer":"Dear Stanley, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:43:55Z"}]},{"id":309521,"entity_id":"wefunder:comment:309521","question":"1. Over the next 5 years, what percentage of revenue is anticipated from Veterinarians and what percentage from medical? 2. Whatis the likelihood of getting FDA approvals?","author_name":"Alan And Leah Sakowitz","votes":2,"created_at":"2025-06-11T07:48:39Z","canonical_url":"https://wefunder.com/synergymed#question-309521","answers":[{"id":309661,"entity_id":"wefunder:comment:309661","answer":"Hi Alan and Leah. Happy to send you a presentation that includes our projection model. Roughly speaking, in the first couple of years, the focus mainly will be on the veterinary market and once the FDA human trials are completed by end of 2026, the human market will gradually become equivalent to the veterinary market. We hope to reach a total revenue of over $100M by 2030 (not guaranteed).","author_name":"Anan Copty","votes":1,"created_at":"2025-06-13T19:35:31Z"},{"id":322769,"entity_id":"wefunder:comment:322769","answer":"Dear Alan and Leah, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:23:11Z"},{"id":329686,"entity_id":"wefunder:comment:329686","answer":"Dear Alan and Leah, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:45:05Z"}]},{"id":297776,"entity_id":"wefunder:comment:297776","question":"Hi, I don't see any mention of patents. Can you please give a brief overview of your IP portfolio? Thanks. Blessings","author_name":"W Kim Colich","votes":2,"created_at":"2024-12-10T10:31:39Z","canonical_url":"https://wefunder.com/synergymed#question-297776","answers":[{"id":297778,"entity_id":"wefunder:comment:297778","answer":"Hi Kim. Very good question. We have two patent applications in Europe and the US. Currently, they are at the review stage. The patents went from provisional to international (PCT) to national (US and Europe). See for example patent number WO2020141527A1 on google patents to get an idea.","author_name":"Anan Copty","votes":1,"created_at":"2024-12-10T12:46:14Z"},{"id":314566,"entity_id":"wefunder:comment:314566","answer":"Hi Kim, we got our patent approved in Europe and the U.S. should follow soon.","author_name":"Yahya Dajani","votes":1,"created_at":"2025-09-08T14:17:26Z"},{"id":329687,"entity_id":"wefunder:comment:329687","answer":"Dear W Kim Colich, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:48:22Z"}]},{"id":292289,"entity_id":"wefunder:comment:292289","question":"I have a few questions. 1) Can you speak to the company's financial performance? I don't see audited financials. Have you filed Form C? What is the company's burn rate? etc. 2) Can you speak your capital structure? Ownership? Shares outstanding and previous fundraising? 3) For the current priced round, can you confirm the pre-money valuation? Price per share?","author_name":"Lance Longwell","votes":2,"created_at":"2024-09-15T01:04:09Z","canonical_url":"https://wefunder.com/synergymed#question-292289","answers":[{"id":296374,"entity_id":"wefunder:comment:296374","answer":"Dear Lance: We recently filed for Form C and the financials should be included as well. The company is owned by two founders mostly, with a few percentages of ownership for angle investors. This round is based on \"Safe\" where, as you know, makes the number of shares and the final valuation dependent on the next large investment following the crowdfunding campaign. The pre-money valuation for the first $100K is $14.4M, a 10% discount compared to $16M after that (after the first $100K). It is possible to raise up to $1.235M with this round.","author_name":"Anan Copty","votes":1,"created_at":"2024-11-16T16:39:02Z"}]},{"id":323322,"entity_id":"wefunder:comment:323322","question":"Is this technology patented and FDA-approved? Also, where is the data/evidence to support use of this technology. Is it evidence-based? How does this influence prognosis and cancer recurrence? Thank you.","author_name":"Earl Stewart","votes":1,"created_at":"2026-01-20T02:06:39Z","canonical_url":"https://wefunder.com/synergymed#question-323322","answers":[{"id":323361,"entity_id":"wefunder:comment:323361","answer":"Dear Earl, Thank you for these thoughtful and important questions—they go directly to the scientific rigor and commercial readiness of our technology. Intellectual Property \u0026amp; Regulatory Status Yes, the core technology is patent-approved, and the company holds protected intellectual property covering its design and therapeutic application. Regarding regulatory status, the technology is not yet FDA-approved, as we are still in the pre–human clinical trial phase. This is expected and appropriate at our current stage of development. FDA approval will follow the completion of clinical trials and regulatory submission. Evidence Base \u0026amp; Supporting Data While human clinical trials have not yet begun, the technology is strongly evidence-based and supported by robust preclinical data: Murine (mouse) studies have already demonstrated clear therapeutic efficacy and safety. These results are publicly highlighted on our WeFunder page. Beyond rodents, we have conducted successful translational studies in dogs, which are especially important because canine cancers closely resemble human cancers in tumor biology, progression, and immune response. Our ongoing canine clinical trial at The Ohio State University is nearing completion, and we expect to publish the results within the next couple of months. This dataset represents a significant validation milestone and a strong bridge between preclinical and human trials. Using large-animal models prior to human trials significantly de-risks development and strengthens both regulatory and investor confidence. Clinical Rationale, Prognosis \u0026amp; Cancer Recurrence Our technology is based on thermal ablation, a well-established and widely studied oncologic modality. Surgical resection remains the gold standard for many solid tumors, but it is often invasive, organ-damaging, and not always feasible depending on tumor location or patient condition. Thermal ablation has been shown in the broader scientific literature to: Achieve local tumor control comparable to surgery in selected cancers Preserve organ structure and function Reduce morbidity, recovery time, and complication rates Our technology is designed to replace or augment surgery, offering a minimally invasive alternative that can improve patient quality of life while maintaining oncologic effectiveness. By effectively destroying tumor tissue in situ, the approach has the potential to: Improve local control Reduce residual disease Positively influence long-term prognosis and recurrence rates, particularly in patients who are poor surgical candidates or where complete resection is challenging Why This Matters for Investment You are investing at a pivotal inflection point: Patent protection is secured Strong preclinical and large-animal data exist A respected academic institution is validating the technology FDA approval represents a clear, value-creating next milestone In short, this is a scientifically grounded, evidence-driven technology with a clear regulatory and clinical pathway, and, meaningful potential to improve cancer outcomes while preserving patient quality of life. We appreciate your diligence and are happy to share additional data or publications as they become available.","author_name":"Anan Copty","votes":3,"created_at":"2026-01-20T19:40:06Z"},{"id":329688,"entity_id":"wefunder:comment:329688","answer":"Dear Earl, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":1,"created_at":"2026-04-01T17:50:15Z"}]},{"id":322945,"entity_id":"wefunder:comment:322945","question":"I noticed that all your perks are the same things except once a year etc, your 100k perk isn't appetizing at all. would be nice if you had a perk etc where investors could get a shirt or just print them for investors. a walking billboards. just on it what you have. \"synergymed cancer treatment technology\" that would stand out big time! most def spark people's interest. can even have a barcode on back where they can get more info. doesn't cost much at all to produce shirts and easy to do a barcode. every company I invested in doing it hundreds of millions annually. two got acquired for almost a billion recently. I can't see how many investors you have but if good amount it's a slam dunk. half the stuff I wear is companies in my portfolio. thanks for your time!","author_name":"John Webster","votes":1,"created_at":"2026-01-13T16:51:57Z","canonical_url":"https://wefunder.com/synergymed#question-322945","answers":[{"id":322948,"entity_id":"wefunder:comment:322948","answer":"Dear John. I am interested in meeting if your time allows. I think a face-to-face meeting would be great. I have some time tomorrow through this calendar if you are available: calendly.com/anan-co…gymed-dr-anan-copty If not, we can figure another time. But, I love your ideas. Simple and easy to do. Looking forward to hearing from you. Best wishes, Anan","author_name":"Anan Copty","votes":1,"created_at":"2026-01-13T18:10:33Z"},{"id":329689,"entity_id":"wefunder:comment:329689","answer":"Dear John, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:51:01Z"}]},{"id":322887,"entity_id":"wefunder:comment:322887","question":"how much is your per share price? several companies on here have a per share price.","author_name":"John Webster","votes":1,"created_at":"2026-01-12T17:08:25Z","canonical_url":"https://wefunder.com/synergymed#question-322887","answers":[{"id":322901,"entity_id":"wefunder:comment:322901","answer":"That’s a great question and a very common one. Because this round is being done via a SAFE, there isn’t a fixed “price per share” today. A SAFE doesn’t convert into shares until our next priced equity round, at which point the price per share is determined. Instead, SAFE investors are protected through the valuation cap and/or discount, which effectively set the maximum price you would pay per share when the SAFE converts. This means you receive shares at a more favorable price than new investors in that future round, reflecting the early risk you’re taking. For example, if our next round is priced at a valuation higher than the SAFE’s valuation cap, your investment would convert as if the company were valued at the cap, resulting in more shares for the same investment. We’re happy to walk through a concrete example based on the SAFE terms if that would be helpful. Note that the startups with share price may have chosen a fixed valuation instead of a SAFE approach.","author_name":"Anan Copty","votes":1,"created_at":"2026-01-12T20:09:30Z"}]},{"id":322886,"entity_id":"wefunder:comment:322886","question":"that's weird I don't see your full response. when I click on your message on the side nothing shows where questions and answers would be. it says see below, let me on the side but won't let me see anything else","author_name":"John Webster","votes":1,"created_at":"2026-01-12T17:06:27Z","canonical_url":"https://wefunder.com/synergymed#question-322886","answers":[{"id":322900,"entity_id":"wefunder:comment:322900","answer":"Hi John. I am not finding the answers either that I posted. Although I wrote the answer twice to your questions because the first time it was erased by the system. The second time it did come up on the screen. Now, I don't see it. Fortunately, I still have the answers. So, I will post them again to answer your questions.","author_name":"Anan Copty","votes":1,"created_at":"2026-01-12T19:56:41Z"}]},{"id":322636,"entity_id":"wefunder:comment:322636","question":"good stuff. I just recently got my feet wet in the medical field, investing in a bunch of medical clinics and growing, therefore, this caught my attention. few questions 1. is your biggest difference between you and the others are that there is no pain etc, things you said? 2. will what you offer be covered by insurance companies? if not how much is it and how long on average will process take? same day etc? 3. the machine you showed how much would that be for clinics etc. 4. if you raise what you are looking for, do you think you will have to raise again? 5. do you have a pitch deck or investor panel? your company would really benefit from it. your video is way too short. I blinked and it was over. people forget you have audio and visual people. me personally I like audio pitch decks that way I can listen as I drive. 6. what is your ultimate exit strategy? thanks for your time!","author_name":"John Webster","votes":1,"created_at":"2026-01-07T16:51:01Z","canonical_url":"https://wefunder.com/synergymed#question-322636","answers":[{"id":322758,"entity_id":"wefunder:comment:322758","answer":"Dear John: Thank you for your questions and for your interest in SynergyMed. Please see my answers below. Let me know if you would like further details. 1. Faster recovery, precise treatment, no damage to healthy tissue, cost saving for insurance companies over surgery, simple utilization of device, patented technology, smart algorithms. 2. There are existing CPT codes for ablation of breast cancer and soft tissue. The cost for the hospitals is $1500 per patient + buying the device. Procedure is also appropriate for outpatient setups and the patient can go home on the same day. 3. For veterinary clinics, $100K and for human hospitals where the device have more capabilities $200K. 4. The crowdfunding campaign is a bridge fund. It helps to get deeper into the veterinary market and if we raise enough, start a few first in human studies. The campaign will help sell veterinary products and generate early revenue from a significant market. For human FDA trials, we will be raising a substantially higher amount through VCs. 5. Yes, and I am happy to send the pitch deck to you by email or through linkedin. Let us connect on LinkedIn https://www.linkedin.com/in/anan-copty-phd-7089a3b/ Here is also a link to a podcast that I had a couple of months ago: https://open.spotify.com/episode/4ifqcM4UaoC1barFbY0nHF?si=MFsImBPpRgOMtbVrg7wmYg so that you can listen while driving And, for best results, happy to have a 1:1 meeting with you to answer any questions. 6. Sell the veterinary part to large pharmaceutical veterinary corporation and sell the human part to a large medical device corporation. We are encouraged by the recent sale of Histosonics, a medical device startup in our space, at a significant valuation of $2.25Billon.","author_name":"Anan Copty","votes":1,"created_at":"2026-01-10T10:29:05Z"}]},{"id":320151,"entity_id":"wefunder:comment:320151","question":"Good to see your new improved website.","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-11-24T15:21:46Z","canonical_url":"https://wefunder.com/synergymed#question-320151","answers":[{"id":320192,"entity_id":"wefunder:comment:320192","answer":"Thank you Thomas. Yes, it needed improvement and we had it reprogrammed.","author_name":"Anan Copty","votes":0,"created_at":"2025-11-25T10:46:55Z"}]},{"id":320072,"entity_id":"wefunder:comment:320072","question":"i found this - https://iaea.shorthandstories.com/rays-of-hope-partner-with-us/index.html","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-11-22T13:38:32Z","canonical_url":"https://wefunder.com/synergymed#question-320072","answers":[{"id":320191,"entity_id":"wefunder:comment:320191","answer":"Thank you Thomas. We will take a look.","author_name":"Anan Copty","votes":1,"created_at":"2025-11-25T10:45:03Z"},{"id":322765,"entity_id":"wefunder:comment:322765","answer":"Dear Thomas, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:18:37Z"}]},{"id":320071,"entity_id":"wefunder:comment:320071","question":"@Anan Copty - I dont know. I can use part of my spare time tp try to find out. But likely youre better to find what fits for you.","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-11-22T13:34:40Z","canonical_url":"https://wefunder.com/synergymed#question-320071","answers":[{"id":320101,"entity_id":"wefunder:comment:320101","answer":"Thank you, Thomas. We appreciate the information.","author_name":"Anan Copty","votes":1,"created_at":"2025-11-23T13:49:35Z"}]},{"id":319952,"entity_id":"wefunder:comment:319952","question":"Have you seen IAEI Rays of Hope https://www.iaea.org/services/key-programmes/rays-of-hope","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-11-19T19:18:17Z","canonical_url":"https://wefunder.com/synergymed#question-319952","answers":[{"id":320070,"entity_id":"wefunder:comment:320070","answer":"Dear Thomas: Thanks for the link. Do you know if they have any grants or funding that we can apply for? Also, if they have any institutions that we can collaborate with?","author_name":"Anan Copty","votes":1,"created_at":"2025-11-22T13:32:41Z"}]},{"id":317023,"entity_id":"wefunder:comment:317023","question":"I tried sending someone to your website for information but they couldn't connect; would you confirm your correct website please","author_name":"Jerry Irwin","votes":1,"created_at":"2025-10-15T05:39:36Z","canonical_url":"https://wefunder.com/synergymed#question-317023","answers":[{"id":319533,"entity_id":"wefunder:comment:319533","answer":"Hi Jerry. This is the correct website link: https://www.synergymeddevices.com . Let us know please if you have any other issues.","author_name":"Anan Copty","votes":0,"created_at":"2025-11-13T11:16:32Z"}]},{"id":315907,"entity_id":"wefunder:comment:315907","question":"Hope you can add at your website possibility to sign up for newsletter.","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-09-29T12:17:45Z","canonical_url":"https://wefunder.com/synergymed#question-315907","answers":[{"id":316251,"entity_id":"wefunder:comment:316251","answer":"Hi Thomas. We send our investors newsletters and constant updates. If you are not an investor, you can follow us on LinkedIn, Instagram, and Facebook or look for open webinars that we hold every now and then. Thank you.","author_name":"Anan Copty","votes":1,"created_at":"2025-10-03T12:25:58Z"}]},{"id":315894,"entity_id":"wefunder:comment:315894","question":"I just came across this article. Does this sound like the same approach? https://news.ohsu.edu/2025/05/14/new-nanoparticle-could-make-cancer-treatment-safer-more-effective","author_name":"Ajit P","votes":1,"created_at":"2025-09-29T00:29:15Z","canonical_url":"https://wefunder.com/synergymed#question-315894","answers":[{"id":316252,"entity_id":"wefunder:comment:316252","answer":"In some sense the approach is similar in that it applies nanoparticles to target cancer tumors such as prostate. There many differences however. Ultrasound is typically used for deep seated tissue. With our electromagnetic approach we are focused on superficial tissue (breast, skin, head \u0026amp; neck ...). Also, electromagnetic waves do not need a medium to travel through. They can travel in air.","author_name":"Anan Copty","votes":1,"created_at":"2025-10-03T12:36:09Z"},{"id":322770,"entity_id":"wefunder:comment:322770","answer":"Dear Ajit, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:24:22Z"},{"id":329690,"entity_id":"wefunder:comment:329690","answer":"Dear Ajit, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:52:09Z"}]},{"id":315004,"entity_id":"wefunder:comment:315004","question":"Hi SYNERGYMED Cancer Treatment Technology Team,I am interested in investing in your company and have a few questions:Do you currently have FDA clearance?Have you conducted any human trials yet? From what I’ve seen, it looks like testing has only been done on mice and dogs so far.If there is no FDA clearance and no human trials, how do you plan to project $100 million in revenue within five years? Where would that revenue come from?Additionally, is your system currently available in any medical facilities and actively being used?Thank you,","author_name":"T Yigo","votes":1,"created_at":"2025-09-16T04:21:12Z","canonical_url":"https://wefunder.com/synergymed#question-315004","answers":[{"id":315017,"entity_id":"wefunder:comment:315017","answer":"Hi T Yigo. SynergyMed is at the pre-clinical stage for humans and clinical for veterinary. Currently, SynergyMed is conducting animal clinical studies on dogs at OSU. The business model contains capital equipment and consumables as described in the page overview. The system is available to be ordered for research facilities or for veterinary hospitals.","author_name":"Anan Copty","votes":1,"created_at":"2025-09-16T13:11:18Z"},{"id":322766,"entity_id":"wefunder:comment:322766","answer":"Dear T Yigo, Thank you again for your interest in SynergyMed and for the thoughtful questions you previously shared. I know that investment decisions require clarity and confidence, and I want to personally ensure all of your questions are fully addressed. We are now in the final three months of our current investment campaign, and I would hate for you to miss this opportunity to join us at this stage of our growth. SynergyMed is at a pivotal point, and we would be excited to have you as part of our journey moving forward. I would be happy to meet with you one-on-one to discuss any remaining questions, walk through our vision in more detail, and explore whether this opportunity aligns with your goals. You can easily schedule a time that works for you using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty I look forward to connecting with you. Sincerely, Anan Copty Founder \u0026amp; CEO, SynergyMed","author_name":"Anan Copty","votes":0,"created_at":"2026-01-10T15:20:15Z"},{"id":329691,"entity_id":"wefunder:comment:329691","answer":"Dear T Yigo, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:53:05Z"}]},{"id":315003,"entity_id":"wefunder:comment:315003","question":"Hi SYNERGYMED Cancer Treatment Technology Team, I am interested in investing in your company and have a few questions:Do you currently have FDA clearance?Have you conducted any human trials yet? From what I’ve seen, it looks like testing has only been done on mice and dogs so far.If there is no FDA clearance and no human trials, how do you plan to project $100 million in revenue within five years? Where would that revenue come from?Additionally, is your system currently available in any medical facilities and actively being used? Thank you","author_name":"T Yigo","votes":1,"created_at":"2025-09-16T04:17:54Z","canonical_url":"https://wefunder.com/synergymed#question-315003","answers":[{"id":315018,"entity_id":"wefunder:comment:315018","answer":"Same question as above. See my answer.","author_name":"Anan Copty","votes":2,"created_at":"2025-09-16T13:11:44Z"}]},{"id":312148,"entity_id":"wefunder:comment:312148","question":"Can it be used to get rid of abscesses?","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-07-30T10:06:33Z","canonical_url":"https://wefunder.com/synergymed#question-312148","answers":[{"id":312150,"entity_id":"wefunder:comment:312150","answer":"Potentially yes. I have seen some papers on the subject. But, this is not our main focus at the moment.","author_name":"Anan Copty","votes":1,"created_at":"2025-07-30T11:50:28Z"}]},{"id":309645,"entity_id":"wefunder:comment:309645","question":"Hi, What is your current revenue?","author_name":"Y S","votes":1,"created_at":"2025-06-13T16:36:36Z","canonical_url":"https://wefunder.com/synergymed#question-309645","answers":[{"id":309662,"entity_id":"wefunder:comment:309662","answer":"Hi Yaacov. We are pre-revenue. We are conducting clinical studies on dogs at this point to start selling the device this year for the veterinary market.","author_name":"Anan Copty","votes":1,"created_at":"2025-06-13T19:36:18Z"},{"id":329693,"entity_id":"wefunder:comment:329693","answer":"Dear Y S, Thank you for your interest in SynergyMed and for taking the time to ask thoughtful questions. I hope we were able to address them to your satisfaction. I wanted to let you know that our crowdfunding campaign will be closing on April 15, 2026, so this is a great time to invest if you’ve been considering it. If you would like to discuss anything further, I would be happy to connect one-on-one. You can schedule a meeting at your convenience using the link below: https://calendly.com/anan-copty-synergymed-ltd/synergymed-dr-anan-copty Thank you again for your interest and support. Best regards, Anan Copty, PhD Founder \u0026amp; CEO","author_name":"Anan Copty","votes":0,"created_at":"2026-04-01T17:54:17Z"}]},{"id":309133,"entity_id":"wefunder:comment:309133","question":"Is this somehting you can use: https://www.terrapower.com/isotopes/","author_name":"Thomas Klauset Aurdal","votes":1,"created_at":"2025-06-04T13:01:11Z","canonical_url":"https://wefunder.com/synergymed#question-309133","answers":[{"id":309320,"entity_id":"wefunder:comment:309320","answer":"This is a different approach and not related to what we do.","author_name":"Anan Copty","votes":1,"created_at":"2025-06-06T22:38:34Z"}]},{"id":308592,"entity_id":"wefunder:comment:308592","question":"How are the nanoparticles specifically targeted to the cancer cells?","author_name":"Oliver John RATCLIFFE","votes":1,"created_at":"2025-05-26T02:44:43Z","canonical_url":"https://wefunder.com/synergymed#question-308592","answers":[{"id":308604,"entity_id":"wefunder:comment:308604","answer":"Hi Oliver. In some technologies, people are developing antibodies or peptides that are placed on the surface of the nanoparticles to attach specifically to a disease. However, those techniques are mostly still in the research and development stage. In our case, we use FDA approved nanoparticles that we inject directly into the tumor. It is also possible to inject them into the blood stream and through a process called the enhanced permeability and retention (EPR) affect, they would bind to the tumor. As EPR has limitations, we prefer to inject directly into the tumor (intratumoral injection). Thank you for the great question, Oliver.","author_name":"Anan Copty","votes":1,"created_at":"2025-05-26T12:13:19Z"}]}],"faq":[{"question":"I have a few questions. 1) Can you speak to the company's financial performance? I don't see audited financials. Have you filed Form C? What is the company's burn rate? etc. 2) Can you speak your capital structure? Ownership? Shares outstanding and previous fundraising? 3) For...","answer":"Dear Lance: We recently filed for Form C and the financials should be included as well. The company is owned by two founders mostly, with a few percentages of ownership for angle investors. This round is based on \"Safe\" where, as you know, makes the number of shares and the final valuation dependent on the next large investment following the crowdfunding campaign. The pre-money valuation for the first $100K is $14.4M, a 10% discount compared to $16M after that (after the first $100K). It is p..."},{"question":"With Q4 well underway/half over, is there an update on the veterinary launch?","answer":"Hi Lance. The product currently is in its final stages and we are waiting on a special grant to help us perform product certification testing. I believe a realistic date for selling the veterinary product is Q2 or Q3 of 2025. These goals are tied with how fast we can raise the funds."},{"question":"Hi, I don't see any mention of patents. Can you please give a brief overview of your IP portfolio? Thanks. Blessings","answer":"Hi Kim. Very good question. We have two patent applications in Europe and the US. Currently, they are at the review stage. The patents went from provisional to international (PCT) to national (US and Europe). See for example patent number WO2020141527A1 on google patents to get an idea."},{"question":"So if your claims are true, how is ist you value this company at only 16M? On top of that how is 100K relevant for you since you claim to be ready to sell in 2025 so how are you going to spend the money what's your burn rate? You said you have 2 main investors and a few angels...","answer":"Hi Stefan. I appreciate your questions. The valuation at $16M is done mostly to give value to our friends, family, network and supporters a chance to invest and be part of the company where otherwise they couldn't. We are seeking a much higher amount later of around $15M with venture capital investors to get us to the FDA trial approval. The valuation will be much higher. We are not seeking a $100K investment with this crowdfunding. The $100K limit is where you get the 10% discount. We are, a..."},{"question":"Hi Anan, I see that the early bird terms was lower from $100,000.00. Is there a specific reason for this change? Thank you, Glenn","answer":"Hi Glenn. I checked with the WeFunder platform. The reason is that some people have invested a large amount, before you did, to exceed the $100K but their investment still hasn't been confirmed, and it is not shown on the platform. On the other hand, there are others who invested twice by mistake so their amount may be removed from the total. So, it depends on whether people confirm their investments or not. I will follow up closely with these people and let you know as soon as I find out. Th..."}]}}}